The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.

But the Centers for Medicare and Medicaid Services said it may reconsider coverage of those drugs in the future, according to a fact sheet on the rule. The proposal would have given millions more ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal ... in a fact sheet at the time. Although Medicare by law is not allowed to cover drugs for ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

CMS said April 4 it will not move forward with a Biden-era proposal to allow Medicare coverage of GLP-1 drugs when prescribed ...